Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Slipicevic

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Gynecologic Oncology|August 6, 2014
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusionsAna Slipicevic, Arild Holth, Ellen Hellesylt, et al.
Biochemical and Biophysical Research Communications|February 22, 2005
Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2Kjersti Jørgensen, Martina Skrede, Véronique Cruciani, et al.
American Journal of Clinical Pathology|September 9, 2005
Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcomeAna Slipicevic, Ruth Holm, Mai T P Nguyen, et al.
Human Pathology|January 6, 2009
Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusionsAna Slipicevic, Geir Frode Øy, Inger Cecilie Askildt, et al.
International Journal of Cancer|July 10, 2009
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanomaGeir Frode Oy, Ana Slipicevic, Ben Davidson, et al.
Plos One|June 22, 2012
High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapyGry Irene Magnussen, Ruth Holm, Elisabeth Emilsen, et al.
BMC Cancer|October 2, 2008
The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cellsAna Slipicevic, Kjersti Jørgensen, Martina Skrede, et al.
BMC Cancer|February 24, 2012
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survivalAna Slipicevic, Ruth Holm, Elisabeth Emilsen, et al.
BMC Cancer|June 10, 2015
Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanomaGry Irene Magnussen, Elisabeth Emilsen, Karianne Giller Fleten, et al.
American Journal of Clinical Pathology|October 20, 2006
Pax-5 expression in nonhematopoietic tissuesEmina Torlakovic, Ana Slipicevic, Chris Robinson, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology|August 6, 2014
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusionsAna Slipicevic, Arild Holth, Ellen Hellesylt, et al.
Biochemical and Biophysical Research Communications|February 22, 2005
Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2Kjersti Jørgensen, Martina Skrede, Véronique Cruciani, et al.
American Journal of Clinical Pathology|September 9, 2005
Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcomeAna Slipicevic, Ruth Holm, Mai T P Nguyen, et al.
Human Pathology|January 6, 2009
Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusionsAna Slipicevic, Geir Frode Øy, Inger Cecilie Askildt, et al.
International Journal of Cancer|July 10, 2009
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanomaGeir Frode Oy, Ana Slipicevic, Ben Davidson, et al.
Plos One|June 22, 2012
High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapyGry Irene Magnussen, Ruth Holm, Elisabeth Emilsen, et al.
BMC Cancer|October 2, 2008
The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cellsAna Slipicevic, Kjersti Jørgensen, Martina Skrede, et al.
BMC Cancer|February 24, 2012
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survivalAna Slipicevic, Ruth Holm, Elisabeth Emilsen, et al.
BMC Cancer|June 10, 2015
Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanomaGry Irene Magnussen, Elisabeth Emilsen, Karianne Giller Fleten, et al.
American Journal of Clinical Pathology|October 20, 2006
Pax-5 expression in nonhematopoietic tissuesEmina Torlakovic, Ana Slipicevic, Chris Robinson, et al.
Pageof 4